Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:XMTR - US98423F1093 - Common Stock

58.47 USD
+0.59 (+1.02%)
Last: 11/28/2025, 8:06:58 PM
58.54 USD
+0.07 (+0.12%)
After Hours: 11/28/2025, 8:06:58 PM
Fundamental Rating

4

XMTR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 49 industry peers in the Trading Companies & Distributors industry. XMTR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XMTR is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

XMTR had positive earnings in the past year.
XMTR had a positive operating cash flow in the past year.
XMTR had negative earnings in each of the past 5 years.
In the past 5 years XMTR always reported negative operating cash flow.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of XMTR (-9.01%) is worse than 85.71% of its industry peers.
With a Return On Equity value of -23.16%, XMTR is not doing good in the industry: 79.59% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.01%
ROE -23.16%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Gross Margin of XMTR (39.29%) is better than 75.51% of its industry peers.
In the last couple of years the Gross Margin of XMTR has grown nicely.
The Profit Margin and Operating Margin are not available for XMTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XMTR has been increased compared to 1 year ago.
Compared to 5 years ago, XMTR has more shares outstanding
The debt/assets ratio for XMTR is higher compared to a year ago.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

XMTR has an Altman-Z score of 4.49. This indicates that XMTR is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.49, XMTR is doing good in the industry, outperforming 73.47% of the companies in the same industry.
XMTR has a Debt/Equity ratio of 1.20. This is a high value indicating a heavy dependency on external financing.
XMTR has a Debt to Equity ratio of 1.20. This is in the lower half of the industry: XMTR underperforms 67.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF N/A
Altman-Z 4.49
ROIC/WACCN/A
WACC8.93%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 3.62 indicates that XMTR has no problem at all paying its short term obligations.
XMTR has a better Current ratio (3.62) than 83.67% of its industry peers.
XMTR has a Quick Ratio of 3.58. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.58, XMTR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.58
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 333.33% over the past year.
Looking at the last year, XMTR shows a very strong growth in Revenue. The Revenue has grown by 22.40%.
The Revenue has been growing by 46.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)333.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%450%
Revenue 1Y (TTM)22.4%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%27.54%

3.2 Future

XMTR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 197.09% yearly.
XMTR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.38% yearly.
EPS Next Y802.35%
EPS Next 2Y317.97%
EPS Next 3Y197.09%
EPS Next 5YN/A
Revenue Next Year21.08%
Revenue Next 2Y19.43%
Revenue Next 3Y18.54%
Revenue Next 5Y19.38%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 208.82, XMTR can be considered very expensive at the moment.
Based on the Price/Earnings ratio, XMTR is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
XMTR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.31.
Based on the Price/Forward Earnings ratio of 75.59, the valuation of XMTR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XMTR indicates a slightly more expensive valuation: XMTR is more expensive than 71.43% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.56. XMTR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 208.82
Fwd PE 75.59
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XMTR's earnings are expected to grow with 197.09% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y317.97%
EPS Next 3Y197.09%

0

5. Dividend

5.1 Amount

XMTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

XOMETRY INC-A

NASDAQ:XMTR (11/28/2025, 8:06:58 PM)

After market: 58.54 +0.07 (+0.12%)

58.47

+0.59 (+1.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-24 2026-02-24/bmo
Inst Owners101.05%
Inst Owner Change-2.31%
Ins Owners5.78%
Ins Owner Change-1.29%
Market Cap3.00B
Revenue(TTM)642.78M
Net Income(TTM)-63.00M
Analysts80
Price Target66.75 (14.16%)
Short Float %12.04%
Short Ratio6.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)50.63%
Min EPS beat(2)4.7%
Max EPS beat(2)96.56%
EPS beat(4)4
Avg EPS beat(4)185.86%
Min EPS beat(4)4.7%
Max EPS beat(4)541.62%
EPS beat(8)8
Avg EPS beat(8)130.07%
EPS beat(12)11
Avg EPS beat(12)93.55%
EPS beat(16)14
Avg EPS beat(16)75.56%
Revenue beat(2)2
Avg Revenue beat(2)3.54%
Min Revenue beat(2)1.79%
Max Revenue beat(2)5.29%
Revenue beat(4)2
Avg Revenue beat(4)1.62%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)5.29%
Revenue beat(8)5
Avg Revenue beat(8)0.87%
Revenue beat(12)6
Avg Revenue beat(12)-0.22%
Revenue beat(16)9
Avg Revenue beat(16)0.04%
PT rev (1m)39.99%
PT rev (3m)39.99%
EPS NQ rev (1m)-10.62%
EPS NQ rev (3m)-10.62%
EPS NY rev (1m)0%
EPS NY rev (3m)2.99%
Revenue NQ rev (1m)4.18%
Revenue NQ rev (3m)4.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 208.82
Fwd PE 75.59
P/S 4.66
P/FCF N/A
P/OCF 278.52
P/B 11.02
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.28
EY0.48%
EPS(NY)0.77
Fwd EY1.32%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)0.21
OCFY0.36%
SpS12.54
BVpS5.31
TBVpS-0.41
PEG (NY)0.26
PEG (5Y)N/A
Graham Number5.78
Profitability
Industry RankSector Rank
ROA -9.01%
ROE -23.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.29%
FCFM N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.71%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.58
Altman-Z 4.49
F-Score5
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)161.93%
Cap/Depr(5y)158.79%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)333.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%450%
EPS Next Y802.35%
EPS Next 2Y317.97%
EPS Next 3Y197.09%
EPS Next 5YN/A
Revenue 1Y (TTM)22.4%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%27.54%
Revenue Next Year21.08%
Revenue Next 2Y19.43%
Revenue Next 3Y18.54%
Revenue Next 5Y19.38%
EBIT growth 1Y18.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year151.04%
EBIT Next 3Y64.61%
EBIT Next 5Y48.65%
FCF growth 1Y77.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.57%
OCF growth 3YN/A
OCF growth 5YN/A

XOMETRY INC-A / XMTR FAQ

What is the fundamental rating for XMTR stock?

ChartMill assigns a fundamental rating of 4 / 10 to XMTR.


What is the valuation status for XMTR stock?

ChartMill assigns a valuation rating of 2 / 10 to XOMETRY INC-A (XMTR). This can be considered as Overvalued.


Can you provide the profitability details for XOMETRY INC-A?

XOMETRY INC-A (XMTR) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for XMTR stock?

The Price/Earnings (PE) ratio for XOMETRY INC-A (XMTR) is 208.82 and the Price/Book (PB) ratio is 11.02.